Index by author

September 01, 2007; Volume 74,Issue 9

  1. Achkar, Jean-Paul

    1. Ulcerative colitis: Responding to the challenges
      Jean-Paul Achkar, MD
      Cleveland Clinic Journal of Medicine September 2007, 74 (9) 657-660;

      Aminosalicylates are the first-line therapy for patients with mild to moderate active ulcerative colitis. Infliximab is now approved for moderately to severely active ulcerative colitis in patients who have had an inadequate response to conventional therapy.

Back to top

In this issue